Jeff Craven

Cover Story

Can Cost-Plus Pricing Lower the Cost of Generic Drugs for Patients?

04/18/2022

Jeff Craven

With the ever-rising costs of medications, new business models and patient care initiatives are becoming increasingly common methods to disrupt the industry to instill lasting change. But how do these recent ventures, like Mark Cuban’s new...

With the ever-rising costs of...

04/18/2022

First Report Managed Care

Literature Review

Examining 177Lu-PSMA-617 as a Treatment for Metastatic Castration-resistant Prostate Cancer

09/16/2021

Jeff Craven

In this literature review, we explore the data from the phase 3 VISION trial recently presented at the 2021 virtual annual meeting of the American Society of Clinical Oncology and published in the New England Journal of Medicine, examining...

In this literature review, we...

09/16/2021

First Report Managed Care